Kirsten D. Erickson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kirsten D. Erickson has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christine B. Mackay
University of Kansas Cancer Center 1 and University of Kansas Medical Center 2, Fairway, KS
2 shared publications Christine Daley
University of Kansas Medical Center 1 and Univiersity of Kansas Cancer Center 2, Fairway, KS
1 shared publicationKerry Hepler
University of Kansas Cancer Center, Fairway, KS
1 shared publication- Roy A. Jensen
University of Kansas Medical Center, Kansas City, KS
1 shared publication - Tami Gurley-Calvez
University of Kansas Medical Center Department of Health Policy and Management Kansas City, KS 66160
1 shared publication
Latest Publications
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , e18174
Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.
E18174 Background: The University of Kansas Cancer Center achieved NCI designation in 2012, and the year prior, acquired 5 outpatient cancer clinics, which contributed to nearly a doubling of the tumor registry cases. Prior to this merger, these practices were part of one of the nation’s largest site management organization networks of community-based oncology practices and were consistently listed as top accruing sites for many of the trials that were conducted. Soon after the merger, clinical trial enrollment dropped significantly, providing a unique opportunity to analyze the reasons for this drastic change in accrual patterns. The primary aim of this study was to identify what factors influence how patients are identified for possible clinical trial participation. Methods: This was a cross-sectional qualitative design. Individual interviews were conducted with 27 physicians and nurse practitioners. Six focus groups included 26 clinical and research staff. Descriptive summary statistics and standard text analysis were performed to summarize responses. Results: The top three factors reported to affect patient identification included: 1) absence of research staff in the clinic, 2) low physician engagement in the clinical trial process, and 3) a general lack of awareness of clinical trials by providers, clinic and research staff. 100% of the providers interviewed agreed that clinical trials are beneficial for patients as well as the practice, and most (98%) agreed the physician is primarily responsible for patient identification. Conclusions: The results from this project support the literature which suggests that physicians are the most significant factor in successful recruitment of patients to cancer clinical trials but adequate organizational support is necessary. Centers considering expanding their network to include community locations should be aware of how organizational changes may affect physician ability to accrue.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , e18174
Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.
E18174 Background: The University of Kansas Cancer Center achieved NCI designation in 2012, and the year prior, acquired 5 outpatient cancer clinics, which contributed to nearly a doubling of the tumor registry cases. Prior to this merger, these practices were part of one of the nation’s largest site management organization networks of community-based oncology practices and were consistently listed as top accruing sites for many of the trials that were conducted. Soon after the merger, clinical trial enrollment dropped significantly, providing a unique opportunity to analyze the reasons for this drastic change in accrual patterns. The primary aim of this study was to identify what factors influence how patients are identified for possible clinical trial participation. Methods: This was a cross-sectional qualitative design. Individual interviews were conducted with 27 physicians and nurse practitioners. Six focus groups included 26 clinical and research staff. Descriptive summary statistics and standard text analysis were performed to summarize responses. Results: The top three factors reported to affect patient identification included: 1) absence of research staff in the clinic, 2) low physician engagement in the clinical trial process, and 3) a general lack of awareness of clinical trials by providers, clinic and research staff. 100% of the providers interviewed agreed that clinical trials are beneficial for patients as well as the practice, and most (98%) agreed the physician is primarily responsible for patient identification. Conclusions: The results from this project support the literature which suggests that physicians are the most significant factor in successful recruitment of patients to cancer clinical trials but adequate organizational support is necessary. Centers considering expanding their network to include community locations should be aware of how organizational changes may affect physician ability to accrue.
- Open Access
- 1 April 2016
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 2, 69-74
Clinical trial insurance coverage for cancer patients under the Affordable Care Act
- 1 April 2016
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 2, 69-74
Open AccessClinical trial insurance coverage for cancer patients under the Affordable Care Act